Effect of short-acting beta blocker on the cardiac recovery after cardiopulmonary bypass

Journal of Cardiothoracic Surgery

Yanning Qian¹  Zhengnian Ding¹  Jie Sun¹ 

[1] Dept. of Anesthesiology, the first affiliated hospital with Nanjing Medical University/Jiangsu province hospital, Nanjing 210029, P.R. China

关键词: arrhythmia;    heart rate;    Mitral valve replacement;    cardiopulmonary bypass;    Esmolol;   

Others  :  1153982
DOI  :  10.1186/1749-8090-6-99

 received in 2011-07-08, accepted in 2011-08-19,  发布年份 2011

【 摘 要 】

The objective of this study was to investigate the effect of beta blocker on cardiac recovery and rhythm during cardiac surgeries. Sixty surgical rheumatic heart disease patients were received esmolol 1 mg/kg or the same volume of saline prior to removal of the aortic clamp. The incidence of cardiac automatic re-beat, ventricular fibrillation after reperfusion, the heart rate after steady re-beat, vasoactive drug use during weaning from bypass, the posterior parallel time and total bypass time were decreased by esmolol treatment. In conclusion: Esmolol has a positive effect on the cardiac recovery in cardiopulmonary bypass surgeries.

【 授权许可】

   
2011 Sun et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Booth JV, Spahn DR, McRae RL, Chesnut LC, El-Moalem H, Atwell DM, Leone BJ, Schwinn DA: Esmolol improves left ventricular function via enhanced beta-adrenergic receptor signaling in a canine model of coronary revascularization. Anesthesilogy 2002, 97:162-169.
• [2]Cork RC, Azari DM, McQueen KA, Aufderheide S, Mitchell M, Naraghi M: Effect of esmolol given during cardiopulmonary bypass on fractional area of contraction from transesophageal echocardiography. Anesth Analg 1995, 81:219-224.
• [3]Sum CY, Yacobi A, Kartzinel R, Stampfli H, Davis CS, Lai CM: Kinetics of esmolol, an ultra-short-acting β-blocker, and of its major metabolite. Clin Pharmacol Ther 1983, 34:427-434.
• [4]Bessho R, Chambers DJ: Myocardial protection with oxygenated esmolol cardioplegia during prolonged normothermic ischemia in the rat. J Thorac Cardiovasc Surg 2002, 124:340-351.
• [5]Scorsin M, Mebazaa A, Al Attar N, Medini B, Callebert J, Raffoul R, Ramadan R, Maillet JM, Ruffenach A, Simoneau F, Nataf P, Payen D, Lessana A: Efficacy of esmolol as a myocardial protective agent during continuous retrograde blood cardioplegia. J Thorac Cardiovasc Surg 2003, 125:1022-1029.
• [6]Fallouh HB, Bardswell SC, McLatchie LM, Shattock MJ, Chambers DJ, Kentish JC: Esmolol cardioplegia: the cellular mechanism of diastolic arrest. Cardiovasc Res 2010, 87:552-560.
• [7]Fannelop T, Dahle GO, Matre K, Moen CA, Mongstad A, Eliassen F, Segadal L, Grong K: Esmolol before 80 min of cardiac arrest with oxygenated cold blood cardioplegia alleviates systolic dysfunction. An experimental study in pigs. Eur J Cardiothorac Surg 2008, 33:9-17.
• [8]Bassiakou E, Xanthos T, Papadimitriou L: The potential beneficial effects of beta adrenergic blockade in the treatment of ventricular fibrillation. Eur J Pharmacol 2009, 616:1-6.
• [9]Jingjun L, Yan Z, Dongdong Z, Guosheng L, Mingwei B: Effect and mechanism of esmolol given during cardiopulmonary resuscitation in a porcine ventricular fibrillation model. Resuscitation 2009, 80:1052-1059.
• [10]Deng CY, Lin SG, Zhang WC, Kuang SJ, Qian WM, Wu SL, Shan ZX, Yang M, Yu XY: Esmolol inhibits Na+ current in rat ventricular myocytes. Methods Find Exp Clin Pharmacol 2006, 28:697-702.
• [11]Killingsworth CR, Wei CC, Dell'Italia LJ, Ardell JL, Kingsley MA, Smith WM, Ideker RE, Walcott GP: Short-acting beta-adrenergic antagonist esmolol given at reperfusion improves survival after prolonged ventricular fibrillation. Circulation 2004, 109:2469-2674.
• [12]Zangrillo A, Turi S, Crescenzi G, Oriani A, Distaso F, Monaco F, Bignami E, Landoni G: Esmolol reduces perioperative ischemia in cardiac surgery: a meta-analysis of randomized controlled studies. J Cardiothorac Vasc Anesth 2009, 23:625-632.
• [13]Chauhan S, Saxena N, Rao BH, Singh RS, Bhan A: A comparison of esmolol and diltiazem for heart rate control during coronary revascularisation on beating heart. Ann Card Anaesth 2000, 3:28-31.
• [14]Arar C, Colak A, Alagol A, Uzer SS, Ege T, Turan N, Duran E, Pamukcu Z: The use of esmolol and magnesium to prevent haemodynamic responses to extubation after coronary artery grafting. Eur J Anaesthesiol 2007, 24:826-831.
• [15]Boldt J, Brosch C, Lehmann A, Suttner S, Isgro F: The prophylactic use of the beta-blocker esmolol in combination with phosphodiesterase III inhibitor enoximone in elderly cardiac surgery patients. Anesth Analg 2004, 99:1009-1017.
• [16]Iliodromitis EK, Tasouli A, Andreadou I, Bofilis E, Zoga A, Cokkinos P, Kremastinos DT: Intravenous atenolol and esmolol maintain the protective effect of ischemic preconditioning in vivo. Eur J Pharmacol 2004, 499:163-169.